Pharmaceutical Technology

JUNE 23, 2025

In 2024, Otsuka announced the acquisition of US-based Jnana Therapeutics in a deal worth up to $1.1bn. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 30, 2025

By incorporating a cell line from AvenCell into good manufacturing practice processes, ViroCell met the challenge of delivering a high-yield vector within the required timeframe. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmacy Times

JULY 22, 2025

Personalized drug selection can lead to faster symptom control, fewer hospitalizations, and improved adherence—all of which contribute to better outcomes and a more streamlined care process. billion in July 2024. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.

Pharmacy Technician

Pharmaceutical Technology

AUGUST 12, 2025

Nanotein Technologies co-founder and CEO Curtis Hodge said: “Nanotein’s soluble activators are designed to improve cell therapy expansion by enhancing the quality and quantity of T cells and providing a feeder-free soluble activator for NK cell activation and expansion, addressing critical challenges in the manufacturing process.”

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 27, 2025

Porton Advanced will apply its knowledge in viral vector technology and CAR-T cell therapy process development to enhance EVA Pharma’s mission to provide safe, effective, and scalable cancer treatments. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 16, 2025

These platforms are designed for safe drug production while allowing scaleable manufacturing processes. mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. The trial data indicated dose-dependent protein production at the site without systemic bioavailability. “By

Insurance Coverage and Processing

Pharmaceutical Commerce

JUNE 16, 2025

With ongoing policy uncertainty, hubs must prioritize adaptable, resilient designs—focusing on process speed, modularity, data tracking, and selecting partners who can evolve with regulatory change. Future-Proofing Hubs is a Must.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 16, 2025

I'll explain why this "gold rush" is fraught with peril, from a risk management and insurance perspective. The elephant in the room: The critical absence of FDA approval The fundamental issue with compounded GLP-1s lies in their sidestepping of the rigorous FDA approval process.

Compounding

Pharmaceutical Technology

JULY 7, 2025

This alliance seeks to bolster clinical trial capabilities through improved regulatory processes and data governance. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. They aim to develop patient-specific treatment protocols while ensuring adherence to rigorous international standards.

Hospitals

Pharmaceutical Technology

JUNE 6, 2025

The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. RFK Jr did not question their importance, and acknowledged panellists’ calls for faster regulatory processes. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Commerce

AUGUST 11, 2025

For the second year in a row, patients with chronic conditions rated health plan access a “D,” with nearly half facing insurance-related barriers like high cost-sharing, formulary restrictions, and prior authorization. Nearly one in three adults (32%) report encountering insurance-related barriers more frequently in 2025 compared to 2024.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 1, 2025

This is not the first in vivo CAR-T relationship that AbbVie has fostered, with a collaboration with Umoja Biopharma in January 2024. According to William Blair, forecast revenue rate from 2024 to 2029 growth rate for AbbVie trails only Eli Lilly and Sanofi, representing an “attractive opportunity” for long-term investors.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 20, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 30, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. This update also suggests we may not see REMS requirements for CD19 and BCMA autologous CAR-T cell therapies in the future,” the research note added. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Insurance Coverage and Processing

Pharmacy Times

JULY 25, 2025

Insurance coverage for GLP-1 medications can be a barrier, as they are often not covered for non-diabetic uses, necessitating pharmacist guidance. 1 It is important to remember that insurance coverage for GLP-1 medications can be a barrier for patients, particularly amid shortages and changes in medications that are being covered.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. MAXSHOT.PL via Shutterstock. FDA approvals do not automatically mean shots enter national immunisation schedules.

Labelling

Pharmaceutical Technology

JULY 9, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 22, 2025

It is important for the patients we serve that Sarepta maintains a productive and positive working relationship with FDA, and it became obvious that maintaining that productive working relationship required this temporary suspension while we address any questions that FDA may have and complete the Elevidys label supplement process.”

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 29, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Despite being a different drug, it is built on the same viral vector as Elevidys, a recombinant adeno-associated viral vector (AAV) called AAVrh74. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

The company is confident that these concerns, which pertain to facilities and processes rather than product quality, can be promptly addressed. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Efforts are underway to work with the FDA to resolve them.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 1, 2025

1 There are specific diseases—including hemophilia and sickle cell disease (SCD)—that are more widespread in groups enrolled in Medicaid than commercially insured individuals, due to the program’s concentration on children, disabled adults, and those families financially impacted by treatment costs. of average manufacturer price.

Insurance Coverage and Processing

Beckers Hospital Review

JULY 17, 2025

to find out one specific way each of them has redesigned a process or care model in the past year to serve more patients — without adding staff. To meet this challenge, Infirmary Health redesigned its clinical documentation integrity process without adding staff. Alaska Mikal Canfield. As a result, CAUTI rates fell 36% below the U.S.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 25, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. GlobalData is the parent company of Clinical Trials Arena. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 16, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 17, 2025

Total deal value in Q1 surged 101% compared to Q4 2024, as per analysis by GlobalData. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Pharma companies rallied to spend a total of $37.7bn. This week alone has already seen deals surpass the billion-dollar mark.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 30, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. His exit raises critical questions: which evidence standards will prevail: traditional or accelerated?” commented Cynthia Pussinen, CEO of Owl Bio Advisors, a life sciences consultancy group. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Beckers Hospital Review

AUGUST 1, 2025

Mr. Angelone, co-founder and chief commercial officer of MacroHealth, has over 25 years of experience in the health insurance and technology industries. Mr. Angelone has also ensured compliance with key regulations like the No Surprises Act and Transparency in Coverage rules, promoting greater transparency in healthcare pricing.

Insurance Coverage and Processing

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 17, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 20, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

BioPharma Dive

JULY 31, 2025

vaccine policymaking process.” The guidelines they put forward, if endorsed by the CDC, can form the basis of insurance coverage and influence health policy. The [ACIP] process has been hijacked with a very specific agenda to undermine the trust and faith in life-saving vaccines,” Goldman said. Kennedy Jr.

Vaccines

Pharmaceutical Technology

JUNE 13, 2025

Moderna’s vaccine, known under the brand name mRESVIA, became the first non-Covid-19 messenger RNA-based (mRNA) vaccine to be approved in the US in May 2024. mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. Give your business an edge with our leading industry insights.

Vaccines

Pharmaceutical Technology

AUGUST 7, 2025

Meanwhile, funding for the Centres for Disease Control (CDC) has been reduced from $9.2bn in 2024 to $4.2bn to accommodate the government’s new health agency, Administration for a Healthy America (AHA), signifying a notable shift in government healthcare priorities.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 23, 2025

Better insights into how SDoH affects health can highlight the systemic influences that leave certain groups with worse health outcomes than others, despite similar health insurance coverage or access. For example, it’s important to consider whether someone has insurance (public or private), a job, and what their income may be.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 10, 2025

Disrupting ACIP’s work introduces dangerous uncertainty about which vaccines will continue to be covered and whether families will have to pay out of pocket for routine immunisations,” the non-profit said. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Vaccines

Pharmaceutical Technology

JUNE 12, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. In 2023, SpliceBio signed a licensing agreement with Spark Therapeutics, allowing the latter to use its protein splicing platform and develop a gene therapy for an undisclosed inherited renal disease.

Insurance Coverage and Processing

Community Pharmacy

NOVEMBER 30, 2023

Created as an insurance coverage plan for those over 65, Medicare offers four levels of benefits that cover everything from hospital insurance to prescription medicine costs. 2024 Medicare Part D Costs Updates While the cost of Part D insurance premiums is expected to decrease from an average of $56.49

Insurance Coverage and Processing